TABLE 1.
Characteristics of Patients at the Time of False Negative 123I-MIBG SPECT
Patient | Age (yr)/Sex | Reason for consult at NIH | Hypersecretion in Plasma | Hypersecretion in Urine | Gene Mutation | ||
---|---|---|---|---|---|---|---|
Meta-nephrines | Cate-cholamines | Meta-nephrines | Cate-cholamines | ||||
1 | 13/F | P | NMN, MN | NE, E, DA | -- | -- | Apparently sporadic |
2 | 47/F | P | NMN, MN | E | NMN, MN, T | None | RET |
3 | 51/F | P | NMN, MN | NE, E | NMN, MN, T | NE, E | Apparently sporadic |
4 | 61/M | P | None | DA | -- | -- | SDHB |
5 | 49/F | P | NMN | NE | NMN, T | NE | Apparently sporadic |
6 | 46/F | P | NMN, MN | None | -- | -- | Apparently sporadic |
7 | 36/F | New P | NMN | NE | NMN, T | NE | SDHB |
8 | 40/F | R | NMN | NE | NMN, T | NE, DA | Apparently sporadic |
9 | 55/M | Met + New P | NMN | NE, DA | NMN, T | NE | Neg for SDHx |
10 | 48/F | Met + New P | NMN | NE, DA | NMN, T | NE, DA | SDHB |
11 | 42/F | Met + New P | NMN | NE, DA | NMN, T | NE | SDHB |
12 | 36/F | Met | NMN | NE | NMN, T | NE | SDHB |
13 | 32/M | Met | NMN, MN | None | None | None | Apparently sporadic |
14 | 47/F | Met | None | None | -- | -- | SDHB |
15 | 43/F | Met | NMN | NMN | NMN, T | None | SDHB |
16 | 34/M | Met | NMN | NE, DA | -- | -- | SDHB |
17 | 37/M | Met | NMN | NE, DA | -- | -- | SDHB |
18 | 43/F | Met | None | None | -- | -- | SDHB |
19 | 45/F | Met | NMN | NE | None | NE | Apparently sporadic |
20 | 33/M | Met | None | None | -- | -- | SDHB |
21 | 22/F | Met | NMN | NE | NMN, T | NE | Apparently sporadic |
Adr: adrenal gland; DA: dopamine; E: epinephrine; F: female; M: male; MN: metanephrine; Met: metastasis; NE: norepinephrine; Neg: Negative; NMN: normetanephrine; P: primary tumor; R: recurrence; RET: rearranged during transfection; SDHB: succinate dehydrogenase subunit B; SDHD: succinate dehydrogenase subunit D; T: total metanephrines; VHL: von Hippel-Lindau
--: not available